Nano Dimension to Form a 3D Bioprinting Subsidiary to Focus on Kidney Disease Bioprinting
Nano Dimension Ltd., a leader in the field of 3D printed electronics, intends to create a platform for 3D bioprinting of cells and connective tissues to form biological structures that function as human kidneys. After conducting market research into applications of the company’s technology to the field of 3D bioprinting, the company has chosen to focus primarily on solutions for end stage kidney disease (“ESRD”), which leads to kidney failure.